Brand Name: Orbactiv
Generic Name: oritavancin
Primary Class: Cytochrome P450 2C19 Inhibitors [MoA]
SPL Set ID: ff09a726-9f9b-4e30-b509-396781293220 view on Dailymed | RXCUI: 1547615
Manufacturer Name: Melinta Therapeutics, LLC
| Package NDC | Description |
|---|---|
| 70842-140-03 | 3 VIAL, GLASS in 1 CARTON (70842-140-03) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (70842-140-01) |